[ad_1]
A vaccine for strep A may not be very profitable for pharmaceutical companies and there are technical challenges that make such vaccines difficult to develop, but early-stage clinical trials are underway
Health
| Analysis
16 December 2022
A transmission electron micrograph of Streptococcus pyogenes ALFRED PASIEKA/SCIENCE PHOTO LIBRARY
As of 16 December, at least 19 children have died in the UK in recent months from an invasive infection of strep A bacteria. On a global scale, the bacteria kill more than half a million people each year. Many of these deaths could be prevented by a vaccine – so why don’t we have one?
Strep A is a bacterium known as group A streptococcus, or Streptococcus pyogenes. It is best known for causing a sore throat, so-called strep throat, and scarlet fever. …
[ad_2]
Source link
